Innovation Theater (Non-Accredited)

Lunch Innovation Theater: Discover Olumiant: A Janus Kinase (JAK) Inhibitor for the Treatment of Moderately to Severely Active Rheumatoid Arthritis (RA) in Adults (Non-Accredited)

Speaker(s)
Andrew Sulich, MD

Sponsored by Lilly, USA